Zydus Wellness CFO Umesh V. Parikh Acquires 250 Equity Shares Worth ₹95,019.00
Zydus Wellness CFO Umesh V. Parikh acquired 250 equity shares worth ₹95,019.00 from BSE on March 2, 2026, increasing his total holding from 18,755 to 19,005 shares. The company disclosed this transaction under SEBI PIT Regulations on March 3, 2026, fulfilling mandatory compliance requirements for designated person share acquisitions.
*this image is generated using AI for illustrative purposes only.
Zydus Wellness Limited has disclosed that its Chief Financial Officer Umesh V. Parikh acquired 250 equity shares of the company from the open market on March 2, 2026. The transaction was disclosed under SEBI (Prohibition of Insider Trading) Regulations, 2015, as required for designated persons of listed companies.
Transaction Details
The share acquisition involved 250 equity shares of ₹2/- each, purchased at a total value of ₹95,019.00 through open market transactions on BSE. This transaction increased Parikh's total shareholding in Zydus Wellness from 18,755 shares to 19,005 shares.
| Parameter: | Details |
|---|---|
| Shares Acquired: | 250 equity shares |
| Share Value: | ₹2/- each |
| Total Transaction Value: | ₹95,019.00 |
| Exchange: | BSE |
| Transaction Date: | March 2, 2026 |
Shareholding Position
Following the acquisition, Parikh's shareholding position in Zydus Wellness has been updated. His total holding increased from 18,755 shares to 19,005 shares, though the percentage shareholding remains at 0.00% as disclosed in the regulatory filing.
| Shareholding Details: | Before Transaction | After Transaction |
|---|---|---|
| Number of Shares: | 18,755 | 19,005 |
| Percentage Holding: | 0.00% | 0.00% |
| Security Type: | Equity Shares | Equity Shares |
Regulatory Compliance
Zydus Wellness filed the disclosure on March 3, 2026, in prescribed Form B under Regulation 7(2) of SEBI PIT Regulations, 2015. The disclosure was signed by Company Secretary and Compliance Officer Nandish P. Joshi and submitted to both BSE Limited and National Stock Exchange of India Limited.
The filing confirms that no derivative trading was involved in this transaction, with all derivative-related fields marked as "N.A." in the regulatory form. This acquisition represents a routine compliance disclosure for insider trading regulations applicable to designated persons of listed companies.
17
